- Potential benefitSupporters could argue the bill prevents irreversible or long‑term medical and surgical interventions on minors, potent…
- Potential benefitBy creating a private right of action with strict liability and long statutes of limitation, the bill could deter provi…
- Potential benefitSupporters may claim reduced future public spending on long‑term care, surgeries, or hormone‑related complications if f…
Chloe Cole Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
This bill (the "Chloe Cole Act") would ban health care professionals, hospitals, and clinics from "participating" in specified chemical or surgical interventions for individuals under 18, defining those interventions to include puberty blockers, cross-sex hormones, and surgeries that alter or remove sex characteristics. The prohibition applies when an interstate-commerce nexus exists (for example, travel, payment, communications, or use of items that traveled interstate) or when the procedure occurs in federal jurisdictions (e.g., DC, territories).
Whether gender-affirming care for minors is medically necessary and safe (Progressives see harm from restricting care; Conservatives see harm from permitting such care).
Relative to its intended legislative type, this bill is a substantive statutory prohibition with a private civil enforcement scheme that is relatively specific in definitions and remedies but incomplete in implementation and fiscal scaffolding.
This bill (the "Chloe Cole Act") would ban health care professionals, hospitals, and clinics from "participating" in specified chemical or surgical interventions for individuals under 18, defining those interventions to include puberty blockers, cross-sex hormones, and surgeries that alter or remove sex characteristics.
The prohibition applies when an interstate-commerce nexus exists (for example, travel, payment, communications, or use of items that traveled interstate) or when the procedure occurs in federal jurisdictions (e.g., DC, territories).
The bill creates a private civil right of action allowing the child subjected as a minor, or the child’s parents/guardians, to sue providers for damages (including compensatory, non-economic, and potentially punitive damages), imposes strict liability if prohibited participation is proven by clear and convincing evidence, and places the burden on providers to prove any enumerated exceptions by clear and convincing evidence.
Judged only on content and legislative patterns, this is a politically and legally contentious, wide‑ranging measure that federalizes a disputed area of pediatric medical practice and creates strong civil remedies. Those features narrow potential bipartisan coalitions and invite litigation and federalism challenges, lowering its overall chance of enactment absent substantial political alignment or package bargaining not evident from the text alone.
Relative to its intended legislative type, this bill is a substantive statutory prohibition with a private civil enforcement scheme that is relatively specific in definitions and remedies but incomplete in implementation and fiscal scaffolding.
Whether gender-affirming care for minors is medically necessary and safe (Progressives see harm from restricting care; Conservatives see harm from permitting such care).
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenCritics could say the bill will reduce access to gender‑affirming care for transgender adolescents, potentially worseni…
- Potential burdenThe bill is likely to increase legal and compliance costs for providers and hospitals (defensive recordkeeping, litigat…
- Federal agenciesBecause the statute creates a federal private cause of action and reaches conduct involving interstate communications o…
Why the argument around this bill splits.
Whether gender-affirming care for minors is medically necessary and safe (Progressives see harm from restricting care; Conservatives see harm from permitting such care).
A mainstream liberal/left-leaning observer would likely view this bill as a broad prohibition that restricts access to gender-affirming medical care for trans and gender diverse youth and as a measure that could chill clinicians from providing evidence-based care.
They would note the private right of action, strict-liability exposure, and the long statute of limitations as creating heavy legal and financial risk for providers and health systems.
They would also emphasize that the bill’s definitions and intent language could be used to second-guess clinical judgment and could deter counseling, referrals, or timely care even though those are explicitly protected to some degree.
A centrist or moderate would likely have a mixed reaction: acknowledging the bill’s intent to protect minors from irreversible procedures while being concerned about legal vagueness, federal overreach, and unintended consequences for medical practice.
They would see legitimate reasons for protecting children and for carving out DSD and detransition care, but they would worry that the definitions of "intent" and "participation," the broad interstate-commerce triggers, and the private right of action with strict liability create a heavy, uncertain burden on clinicians and hospitals.
Centrists would also be attentive to fiscal effects of litigation and potential disruption to continuity of care, and would want clearer standards, due process for providers, and alignment with medical evidence.
A mainstream conservative observer would generally view this bill positively as a strong federal tool to prevent what they would describe as irreversible chemical or surgical interventions on minors and to hold providers accountable.
They would emphasize protecting children from experimental or ideologically driven treatments, reinforcing parental rights, and creating civil remedies for families harmed by such interventions.
The interstate-commerce triggers would be seen as a practical means to create nationwide reach where necessary, and the strict liability and extended statute of limitations would be viewed as ensuring effective deterrence and relief.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Judged only on content and legislative patterns, this is a politically and legally contentious, wide‑ranging measure that federalizes a disputed area of pediatric medical practice and creates strong civil remedies. Those features narrow potential bipartisan coalitions and invite litigation and federalism challenges, lowering its overall chance of enactment absent substantial political alignment or package bargaining not evident from the text alone.
- No cost estimate or Congressional Budget Office scoring is included; the magnitude of potential financial liability and effects on insurers and health systems are unknown and could influence legislative appetite.
- The bill's broad interstate commerce triggers and retroactive application of a private right of action for past conduct raise legal uncertainty (e.g., due process, retroactivity, preemption, and equal‑protection challenges) that could affect support and judicial outcomes.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Whether gender-affirming care for minors is medically necessary and safe (Progressives see harm from restricting care; Conservatives see ha…
Judged only on content and legislative patterns, this is a politically and legally contentious, wide‑ranging measure that federalizes a dis…
Relative to its intended legislative type, this bill is a substantive statutory prohibition with a private civil enforcement scheme that is relatively specific in definitions and remedies but incomplete in implementatio…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.